Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.
Clinical trial NCT05838768 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05838768
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-27
- Primary completion
- 2027-08-31
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.